AHRQ No Evidence to Support Off-Label Uses of Atypical Antipsychotics
"Most off-label use occurs without scientific support."
-
-
Eli Lilly Documents Show Risks of Zyprexa were deliberately played down_NYT
NY Times reports: In March 2002, Lilly rejected plans to give psychiatrists guidance about how
to treat diabetes, "worrying that doing so would tarnish Zyprexa's reputation." -
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.
-
Psychiatric Drug Mix for Young On Shaky Grounds_ NYTimes
The lead story in The New York Times on Thanksgiving day (below) acknowledged several facts demonstrating that children are the victims of major medical malpractice:
-
Psychiatry operates within a pre-Copernican framework of science
Dr. E. Jane Costello, a professor of psychiatry and behavioral sciences at Duke University, acknowledges: “The system of diagnosis is still 200 to 300 years behind other branches of medicine.” Psychiatry also fails to be guided by an evidence-based positive benefit / risk assessment of its prescribed treatments.
-
Psychiatrist Challenges Ethics of Yale Drug Experiment
The ethics of this radical drug experiment is being challenged by Dr. Jerald Block, a forthright psychiatrist and experienced system's analyst. His critical appraisal, published in the Bioethics Forum, Hastings Center Report.
-
Big Pharma Cashing In Like Robber Barrons on Medicare Rx Drug Law_NYT
The New York Times reports: "For big drug companies, the new Medicare prescription benefit is proving to be a financial windfall larger than even the most optimistic Wall Street analysts had predicted."
-
Infant Mental Health Screen-a Gov-approved Assault
An Orwellian nightmare is being implemented on infants even as the evidence demonstrates that the psychiatry's practice guidelines are corrupted by
industry. -
Scientific Fraud: Eric Poehlman / Richard Borison
Medical researchers who commit fraud and research misconduct are caught only when a person of conscience steps up to the plate and blows the whistle. There are no systemic, independent checks and balances to prevent research fraud or abuse of patients.
-
FDA: Regulatory Protections for Children. Comments by Sharav, Noble, & Fishman for AHRP
FDA: regulatory protections for children. Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP August 6, 2001 To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville,…
-
Dissenting Opinion: Against waiving parental permission for research
Dissenting Opinion: Against Waiving Parental Permission for Research July 25, 2001 To: Mary Faith Marshall, Ph.D, Chairperson, National Human Research Protections Advisory Committee Department of Health and Human Services Re: Specific Comment on FDA’s Decision to Adopt HHS 45 CFR 46 Subpart D, EXCLUDING §46.408 (c) Dissenting opinion of Vera…
-
NGO Probe to Look at Foster Kids in AIDS Drug Trials – NYC
NGO Probe to Look at Foster Kids in AIDS Drug Trials – NYC Sat, 23 Apr After a year of stonewalling, the New York City Administration for Children’s Services has announced that it would seek “an independent review” of the AIDS drug trials that were conducted on children in the…